Atomoxetine Capsules Recalled for N-Nitroso Impurity Above FDA Limits
Glenmark Pharmaceuticals is recalling Atomoxetine capsules due to N-Nitroso impurity levels exceeding FDA recommended limits. The recall affects 56,208 bottles nationwide with specific lot numbers.
- Product
- ATOMOXETINE — ATOMOXETINE (ATOMOXETINE)
- Category
- Drug
- Distribution
- Distributed nationwide